A detailed history of Williams & Novak, LLC transactions in Cerus Corp stock. As of the latest transaction made, Williams & Novak, LLC holds 14,715 shares of CERS stock, worth $20,601. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,715
Previous 13,115 12.2%
Holding current value
$20,601
Previous $18.5 Million 26.52%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$1.16 - $1.6 $1,855 - $2,560
1,600 Added 12.2%
14,715 $23.4 Million
Q2 2025

Jul 24, 2025

BUY
$1.22 - $1.51 $225 - $279
185 Added 1.43%
13,115 $18.5 Million
Q1 2025

May 15, 2025

BUY
$1.39 - $2.15 $17,972 - $27,799
12,930 New
12,930 $17.8 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $248M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Williams & Novak, LLC Portfolio

Follow Williams & Novak, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Williams & Novak, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Williams & Novak, LLC with notifications on news.